Showing results (71-80 of 77) with videos related to
Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 77 results.
Current Cancer Drug Targets|November 15, 2006
Oncogene-blocking therapies: new insights from conditional mouse tumor modelsJ G Hengstler, E O Bockamp, M Hermes, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 10, 2006
ErbB-3 predicts survival in ovarian cancerBerno Tanner, Dirk Hasenclever, Katja Stern, et al.Cancer Research|February 12, 2005
Premature senescence is a primary fail-safe mechanism of ERBB2-driven tumorigenesis in breast carcinoma cellsTatjana M Trost, Ekkehart U Lausch, Stephan A Fees, et al.Cancer Research|April 6, 2006
ERBB2-mediated transcriptional up-regulation of the alpha5beta1 integrin fibronectin receptor promotes tumor cell survival under adverse conditionsChristian Spangenberg, Ekkehart U Lausch, Tatjana M Trost, et al.British Journal of Cancer|May 6, 2008
Trastuzumab therapy vs tetracycline controlled ERBB2 downregulation: influence on tumour development in an ERBB2-dependent mouse tumour modelM Hermes, W Schormann, M Brulport, et al.Cancer Research|November 13, 2003
Switching off HER-2/neu in a tetracycline-controlled mouse tumor model leads to apoptosis and tumor-size-dependent remissionIlka B Schiffer, Susanne Gebhard, Carolin K Heimerdinger, et al.Biochemical and Biophysical Research Communications|September 24, 2004
4-Epidoxycycline: an alternative to doxycycline to control gene expression in conditional mouse modelsK Eger, M Hermes, K Uhlemann, et al.Pageof 8